Approval · Notice of Compliance 34373 · 2024
MICRO+6 REGULAR: Notice of Compliance 34373
Issued November 13, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34373
- Date
- November 13, 2024
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of new strength. Change in the composition of a dosage form. Addition of a primary container closure system
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MICRO+6 REGULAR | 02552787 | Marketed |
Medicinal ingredients
- CHROMIC CHLORIDE 2 MCG per ML
- CUPRIC SULFATE 60 MCG per ML
- MANGANESE SULFATE 11 MCG per ML
- SELENIUM DIOXIDE 12 MCG per ML
- SODIUM IODIDE 15 MCG per ML
- ZINC SULFATE 1 MG per ML